Vitamin D Testing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Product (25-Hydroxy Vitamin D Testing, 1,25-Dihydroxy Vitamin D Testing, 24,25-Dihydroxy Vitamin D Testing), By Indication (Osteoporosis, Rickets, Thyroid Disorders, Malabsorption, Vitamin D Deficiency, Others), By End User (Diagnostic Laboratories, Hospitals and Clinics, Homecare Settings, Others), By Region and Competition 2027

Global Vitamin D testing market is expected to grow with an impressive growth rate in the next five years on the account of rise in the geriatric population along with the increase in the chronic diseases like diabetes Type 2, kidney diseases, Crohn’s disease, and celiac disease, the increasing number of infections and autoimmune diseases, a growing number of strategic developments by vendors and innovative product offerings by vendors. The chronic diseases are rapidly growing at an alarming rate and need to find the drug that can overcome the disease and acts as a treatment further.

Vitamin D is an essential nutrient that plays a crucial role in maintaining bone health and regulating the immune system. A deficiency of Vitamin D can lead to various health problems such as osteoporosis, rickets, and an increased risk of certain types of cancer. As a result, there has been a growing emphasis on the need for Vitamin D testing to detect and monitor Vitamin D deficiency in individuals.

Furthermore, the ongoing research and development, clinical trials, approval and commercialization of new clinical tests, geographical expansions and governmental support toward the research and development, are expected to boost the market growth of global Vitamin D testing market during the next five years.

Increasing incidence of Vitamin D deficiency

Vitamin D absorbs and retains calcium to the body, therefore, can reduce cancer cell growth, help control infections and reduce inflammation. The deficiency of Vitamin D affects many populations. This is due to minimum exposure to sunlight, decreased endogenous synthesis, low intake of Vitamin D, poor absorption of food, consumption of phenytoin and phenobarbital, and changes in lifestyles. As per the data of National Center for Biotechnology Information (NCBI), National Institute of Health 2022, Vitamin D deficiency is a global public health issue in which around 1 billion people worldwide have Vitamin D deficiency, while 50% of the population has Vitamin D insufficiency. The prevalence of patients with Vitamin D deficiency is highest in the elderly, obese patients, nursing home residents, and hospitalized patients. The prevalence of Vitamin D deficiency was 35% higher in obese people irrespective of latitude and age. For instance,in United States, about 50% to 60% of nursing home residents and hospitalized patients have Vitamin D deficiency as per NCBI. Therefore, these factors are majorly responsible for propelling the growth of Global Vitamin D Testing Market.

Rising Prevalence of Chronic Diseases

Several chronic diseases, such as osteoporosis, cardiovascular disease, and diabetes, have been linked to Vitamin D deficiency. As the global prevalence of these diseases continues to rise, there is a growing demand for Vitamin D testing to identify individuals at risk and to guide treatment strategies. The critical roles of Vitamin D in several endocrine, paracrine, and autocrine activities have been specified in various studies. Vitamin D deficiency in adults acts as a key factor for the development of various communicable and non-communicable diseases. For instance, inadequate levels of Vitamin D play a major role for the development of diseases like colon cancer, breast cancer, cardiovascular diseases, diabetes mellitus, multiple sclerosis, rheumatoid arthritis, Parkinson’s disease, tuberculosis etc. Despite the high physiological importance, deficiency of this vitamin is commonly reported around the world. According to the reports, approximately 1 billion people worldwide are affected with vitamin-D deficiency and around 50% of the global population have Vitamin D insufficiency. Additionally, the prevalence of Vitamin D deficiency in Europe, USA and Middle East has been reported to range from 20% to 90%.

Several factors have been highlighted as underlying variables to explain this world-wide variation of Vitamin D status among different populations. Degree of sunlight exposure and the factors that influence its duration and intensity ultimately influence the level of Vitamin D amongst population.

For instance, in April 2020, according to an article published by WebMD LLC, it was reported that the global prevalence of IBD is 396 cases per 100,000 persons annually. Also, the patients are suffering from Vitamin D deficiency is seeking medical attention for the treatment of Vitamin D deficiency and rising in a economic burden. Eventually, this led to increase initiatives for awareness campaigns regarding the importance of Vitamin D by the government and other for profit and non-profit organizations.

Recent developments & Product Launches

Rapid advancements and development practices are propelling the growth of the market on account of growing need of developing new policies of Vitamin D testing market for the preventive measures of Vitamin D deficiency. For instance, in November 2020, Omega Quant launched a Vitamin D test with a sample collection kit, allowing normal levels to be tested at home. The method was safe, simple, and convenient test requires just a finger stick and a couple drops of blood for analysis in the range of omega-3 blood tests. Secondly in March 2020, Thermo Fisher Scientific announced the availability of the Cascadion SM clinical analyzer for the Cascadion SM 25-Hydroxy Vitamin D assay in the United States, with the goal of expanding its brand presence for the increasing the demand for the growth of global Vitamin D testing market. Additionally,

In 2021, a nutrition firm namely Royal DSM launched a digital campaign in India with the aim of raising awareness among the people for routine check-ups of Vitamin D levels in the body. Hence, shows an impressive growth of the Global Vitamin D Testing Market.

Increasing Adoption of Point-Of-Care Testing

POC testing allows healthcare professionals to quickly and accurately diagnose vitamin D deficiency, without the need for laboratory testing. This is particularly important in regions with limited access to laboratory facilities or where patients may have difficulty accessing care. In addition to POC testing, there has been a significant increase in the number of vitamin D testing laboratories worldwide. These laboratories offer a range of vitamin D testing services, including serum testing, dried blood spot testing, and saliva testing. Many of these laboratories also offer personalized vitamin D supplementation recommendations based on the results of the testing. POCT enables healthcare professionals to provide a more personalized approach to patient care, by tailoring treatment plans based on immediate test results. POCT is particularly useful in emergency situations, where time is of the essence, and accurate diagnosis is critical. According to the National Institutes of Health (NIH), more than one billion people worldwide are estimated to have vitamin D deficiency, which can lead to a range of health problems, including weakened bones, muscle weakness, and an increased risk of certain cancers. Hence, it shows an impressive growth of the Global Vitamin D Testing Market.

Download Free Sample Report

Market Segmentation

Global Vitamin D Testing Market can be segmented based on by product, by indication, by end user, and by region. Based on product, the market can be categorized into 25-Hydroxy Vitamin D Testing, 1,25-Dihydroxy Vitamin D Testing, 24,25-Dihydroxy Vitamin D Testing. Based on indication, the market can be fragmented into Osteoporosis, Rickets, Thyroid Disorders, Malabsorption, Vitamin D Deficiency, and others. Based on end user, the market can be grouped into diagnostic laboratories, hospitals and clinics, homecare settings, and others.

Company Profiles

Hoffmann-La Roche Ltd., Abbott Laboratories Ltd., Siemens Corporation Ltd., Danaher Corporation Ltd., Quest Diagnostics, Inc., BioMerieux SA, DiaSorin S.p.A., Thermo Fisher Scientific Inc., Quidel Corporation Ltd., Beckman Coulter Inc., Biokit S.A., Tosoh Bioscience, Inc., Qualigen Inc., Diazyme Laboratories, Inc., Hologic, Inc., etc. are some of the key players operating in the global Vitamin D testing market.

Report Scope:

In this report, global Vitamin D testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Global Vitamin D Testing Market, By Product:
• 25-Hydroxy Vitamin D Testing
• 1,25-Dihydroxy Vitamin D Testing
• 24,25-Dihydroxy Vitamin D Testing
• Global Vitamin D Testing Market, By Indication:
• Osteoporosis
• Rickets
• Thyroid Disorders
• Malabsorption
• Vitamin D Deficiency
• Others
• Global Vitamin D Testing Market, By End User:
• Diagnostic Laboratories
• Hospitals and Clinics
• Homecare Settings
• Others
• Global Vitamin D Testing Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Turkey
• Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Vitamin D Testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Vitamin D Testing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]